0J6Z Stock Overview
Provides medical and specialty insurance products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Humana Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$296.78 |
| 52 Week High | US$525.00 |
| 52 Week Low | US$208.71 |
| Beta | 0.52 |
| 11 Month Change | 13.87% |
| 3 Month Change | -16.08% |
| 1 Year Change | -42.48% |
| 33 Year Change | -30.74% |
| 5 Year Change | -13.25% |
| Change since IPO | 2.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0J6Z | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 7.3% | 1.4% | 1.7% |
| 1Y | -42.5% | -22.1% | 8.3% |
Return vs Industry: 0J6Z underperformed the UK Healthcare industry which returned -22.6% over the past year.
Return vs Market: 0J6Z underperformed the UK Market which returned 8% over the past year.
Price Volatility
| 0J6Z volatility | |
|---|---|
| 0J6Z Average Weekly Movement | 7.6% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0J6Z's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0J6Z's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 67,600 | Jim Rechtin | www.humana.com |
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals.
Humana Inc. Fundamentals Summary
| 0J6Z fundamental statistics | |
|---|---|
| Market cap | US$35.90b |
| Earnings (TTM) | US$1.36b |
| Revenue (TTM) | US$115.01b |
26.4x
P/E Ratio0.3x
P/S RatioIs 0J6Z overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0J6Z income statement (TTM) | |
|---|---|
| Revenue | US$115.01b |
| Cost of Revenue | US$98.07b |
| Gross Profit | US$16.95b |
| Other Expenses | US$15.59b |
| Earnings | US$1.36b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 29, 2025
| Earnings per share (EPS) | 11.29 |
| Gross Margin | 14.73% |
| Net Profit Margin | 1.18% |
| Debt/Equity Ratio | 75.9% |
How did 0J6Z perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield32%
Payout RatioDoes 0J6Z pay a reliable dividends?
See 0J6Z dividend history and benchmarks| Humana dividend dates | |
|---|---|
| Ex Dividend Date | Dec 31 2024 |
| Dividend Pay Date | Jan 31 2025 |
| Days until Ex dividend | 35 days |
| Days until Dividend pay date | 66 days |
Does 0J6Z pay a reliable dividends?
See 0J6Z dividend history and benchmarks